NexgenRx Inc.
NEGXF
$0.20
$0.00351.78%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.41% | -6.54% | |||
| Total Other Revenue | -4.97% | 2.03% | |||
| Total Revenue | 2.14% | -6.24% | |||
| Cost of Revenue | 10.11% | 0.15% | |||
| Gross Profit | -0.13% | -7.91% | |||
| SG&A Expenses | -2.75% | 4.93% | |||
| Depreciation & Amortization | -3.57% | -0.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.09% | 3.36% | |||
| Operating Income | 99.03% | -82.63% | |||
| Income Before Tax | 1,304.55% | -97.97% | |||
| Income Tax Expenses | -0.60% | 1.76% | |||
| Earnings from Continuing Operations | 369.53% | -93.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 369.53% | -93.19% | |||
| EBIT | 99.03% | -82.63% | |||
| EBITDA | 17.76% | -48.68% | |||
| EPS Basic | 400.00% | -93.75% | |||
| Normalized Basic EPS | 700.00% | -96.55% | |||
| EPS Diluted | 400.00% | -93.33% | |||
| Normalized Diluted EPS | 700.00% | -96.43% | |||
| Average Basic Shares Outstanding | 0.23% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.21% | 5.23% | |||
| Dividend Per Share | -100.00% | -- | |||
| Payout Ratio | -0.98% | 168.60% | |||
